mRNA-Encoded Cytokines for the Treatment of Advanced Solid Tumors

Time: 2:30 pm
day: Pre-Event Content


  • Uncover the IL-2 variant encoded by mRNA clinical development as a next-generation IL-2 therapy with potentially better pharmacokinetics, safety and efficacy profile
  • Analyze the co-developed IL-2wt and IL-7wt encoded by mRNA is a potent combination partner for cancer vaccines
  • Assess how the BioNTech proprietary RiboCytokine addresses the limitations of recombinantly expressed cytokines